Kai‐Hsiung Chang

1.3k total citations
35 papers, 973 citations indexed

About

Kai‐Hsiung Chang is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Kai‐Hsiung Chang has authored 35 papers receiving a total of 973 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 10 papers in Molecular Biology and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Kai‐Hsiung Chang's work include Prostate Cancer Treatment and Research (10 papers), Hormonal and reproductive studies (8 papers) and AI-based Problem Solving and Planning (6 papers). Kai‐Hsiung Chang is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Hormonal and reproductive studies (8 papers) and AI-based Problem Solving and Planning (6 papers). Kai‐Hsiung Chang collaborates with scholars based in United States, Taiwan and South Korea. Kai‐Hsiung Chang's co-authors include Nima Sharifi, Rui Li, Richard J. Auchus, Yan D. Zhao, Lori Watumull, Mahboubeh Papari-Zareei, Jiayan Liu, Peter S. Nelson, Yair Lotan and Robert L. Vessella and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Kai‐Hsiung Chang

31 papers receiving 956 citations

Peers

Kai‐Hsiung Chang
Olga A. Iakoubova United States
Ariel Brautbar United States
Frank S Ong United States
Matthew J. Sikora United States
Mark Bouzyk United States
Olga A. Iakoubova United States
Kai‐Hsiung Chang
Citations per year, relative to Kai‐Hsiung Chang Kai‐Hsiung Chang (= 1×) peers Olga A. Iakoubova

Countries citing papers authored by Kai‐Hsiung Chang

Since Specialization
Citations

This map shows the geographic impact of Kai‐Hsiung Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai‐Hsiung Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai‐Hsiung Chang more than expected).

Fields of papers citing papers by Kai‐Hsiung Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai‐Hsiung Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai‐Hsiung Chang. The network helps show where Kai‐Hsiung Chang may publish in the future.

Co-authorship network of co-authors of Kai‐Hsiung Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Kai‐Hsiung Chang. A scholar is included among the top collaborators of Kai‐Hsiung Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai‐Hsiung Chang. Kai‐Hsiung Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Chung‐Hsin, Hsiang–Po Huang, Kai‐Hsiung Chang, et al.. (2024). Predicting Clinically Significant Prostate Cancer Using Urine Metabolomics via Liquid Chromatography Mass Spectrometry. The World Journal of Men s Health. 43(2). 376–376. 2 indexed citations
2.
Park, S.-H., Eunhee Park, Eun‐Ju Lee, et al.. (2023). Evolocumab, a PCSK9 inhibitor, suppresses abdominal aortic aneurysm progression in mice. Atherosclerosis. 379. S42–S43. 1 indexed citations
3.
Lin, Hsin-Ying, Chun‐Jung Ko, Shaowei Lan, et al.. (2022). Matriptase-2/NR4A3 axis switches TGF-β action toward suppression of prostate cancer cell invasion, tumor growth, and metastasis. Oncogene. 41(20). 2833–2845. 9 indexed citations
4.
Huang, Shih‐Han, Christo J. F. Muller, Kai‐Hsiung Chang, et al.. (2022). Aspalathus linearis suppresses cell survival and proliferation of enzalutamide-resistant prostate cancer cells via inhibition of c-Myc and stability of androgen receptor. PLoS ONE. 17(7). e0270803–e0270803. 5 indexed citations
5.
Chang, Kai‐Hsiung, et al.. (2021). Profiling essential genes in human mammary cells by multiplex RNAi screening. UNC Libraries.
6.
Li, Jianneng, Mohammad Alyamani, Ao Zhang, et al.. (2017). Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer. eLife. 6. 98 indexed citations
7.
Hearn, Jason W.D., Chad A. Reichard, C.A. Reddy, et al.. (2016). HSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort study. The Lancet Oncology. 17(10). 1435–1444. 103 indexed citations
8.
Chang, Kai‐Hsiung, Rui Li, Barbara Kuri, et al.. (2013). A Gain-of-Function Mutation in DHT Synthesis in Castration-Resistant Prostate Cancer. Cell. 154(5). 1074–1084. 242 indexed citations
9.
Li, Rui, Kamalesh Kumar Sharma, Kai‐Hsiung Chang, et al.. (2012). Abiraterone Inhibits 3β-Hydroxysteroid Dehydrogenase: A Rationale for Increasing Drug Exposure in Castration-Resistant Prostate Cancer. Clinical Cancer Research. 18(13). 3571–3579. 81 indexed citations
10.
Chang, Kai‐Hsiung & Nima Sharifi. (2012). Prostate cancer—from steroid transformations to clinical translation. Nature Reviews Urology. 9(12). 721–724. 17 indexed citations
11.
Ding, Zhiyang, Shu Yin, Xiao Qin, et al.. (2012). Multicore-Enabled Smart Storage for Clusters. 108–116. 1 indexed citations
12.
Chang, Kai‐Hsiung, Rui Li, Mahboubeh Papari-Zareei, et al.. (2011). Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer. Proceedings of the National Academy of Sciences. 108(33). 13728–13733. 270 indexed citations
13.
Kinzy, Terri Goss, Anthony M. Esposito, Jennifer Hurley, et al.. (2008). A birth‐to‐death view of mRNA from the RNA recognition motif perspective. Biochemistry and Molecular Biology Education. 36(1). 1–8. 1 indexed citations
14.
Lambert, Bruce L., Chiahung Chou, Kai‐Hsiung Chang, Eskinder Tafesse, & William H. Carson. (2005). Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case‐control study of California Medicaid claims. Pharmacoepidemiology and Drug Safety. 14(6). 417–425. 53 indexed citations
15.
Hu, Wen‐Chen, Kai‐Hsiung Chang, & Gerhard X. Ritter. (2000). Web document classification using modified decision trees. 262–263. 3 indexed citations
16.
Chang, Kai‐Hsiung, et al.. (1992). A framework for intelligent test data generation. Journal of Intelligent & Robotic Systems. 5(2). 147–165. 7 indexed citations
17.
Chang, Kai‐Hsiung & William G. Wee. (1985). A knowledge based planning system for mechanical assembly usign robots. Design Automation Conference. 330–336. 3 indexed citations
18.
Chang, Kai‐Hsiung & William G. Wee. (1985). A Planning System with Analysis.. 8(4). 275–280.
19.
Chang, Kai‐Hsiung, et al.. (1985). A Knowledge Based Planning System for Mechanical Assembly Using Robots. sme 11. 330–336. 4 indexed citations
20.
Chang, Kai‐Hsiung, et al.. (1979). Leukocyte counts and arterial blood gases in nonrenal psoriatic patients treated with extracorporeal devices: Preliminary report.. PubMed. 9. 133–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026